U.S. FDA approves Medtronic heart valve replacement system

Medtronic Inc's non-invasive systems for replacing diseased heart valves won U.S. approval for use in patients deemed too frail to endure traditional open heart surgery, the U.S. medical device maker said on Friday.

_0">

The Food and Drug Administration approved Medtronic's CoreValve system based on U.S. clinical trials in which it was shown to be safe and effective while demonstrating low rates of stroke and valve leakage, the company said.

CoreValve, in which the replacement valve is threaded into place through an artery using a catheter, spares patients chest-cracking surgery. The system has been available since 2007 in Europe, where it is not uncommon for medical devices to win approval several years ahead of the United States.

(Reporting by Bill Berkrot; Editing by Lisa Von Ahn)

Popular posts from this blog

Model Stella Tennant dies 'suddenly' aged 50 as her family pay tribute to 'wonderful woman and an inspiration to us all'

ALL ABOUT CAR INSURANCE:

Video shows cracks in Champlain Towers a YEAR before Surfside condo collapsed: Prospective buyer says she didn't buy a condo there after seeing flaws in parking garage - as death toll rises to 78